头颈部癌症放射治疗的争议与展望：基于文献的批判性综述。
Radiotherapy Controversies and Prospective in Head and Neck Cancer: A Literature-Based Critical Review.
机构信息
Department of Radiotherapy, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.
Department of Oral and Maxillo Facial Sciences, Policlinico Umberto I "Sapienza" University of Rome, Italy.
出版信息
Neoplasia. 2018 Mar;20(3):227-232. doi: 10.1016/j.neo.2018.01.002. Epub 2018 Feb 12.
Abstract
In treating head and neck cancer (HNC), the objectives are provided for best functional results and minimal risk of serious complications. The choice of appropriate management depends primarily on specific site and stage of primary tumor at diagnosis. Radiation therapy (RT) with or without concomitant chemotherapy represents a classical treatment option. In this review, we provide an update of recent research strategies to counteract the existing damage caused by RT and highlight clinical trials currently in progress. We discuss the challenges in the evaluation of new stage system and RT-related toxicity onset. We mainly address the deficiencies and the advantages noted in the current treatment era.
摘要
在治疗头颈部癌症（HNC）时，目标是提供最佳的功能结果和最小的严重并发症风险。适当的治疗方法的选择主要取决于诊断时原发性肿瘤的特定部位和阶段。放射治疗（RT）联合或不联合化疗是一种经典的治疗选择。在这篇综述中，我们提供了最近对抗 RT 引起的现有损伤的研究策略的更新，并强调了目前正在进行的临床试验。我们讨论了在评估新的分期系统和 RT 相关毒性发生方面的挑战。我们主要讨论了在当前治疗时代注意到的缺陷和优势。
相似文献
1
Radiotherapy Controversies and Prospective in Head and Neck Cancer: A Literature-Based Critical Review.头颈部癌症放射治疗的争议与展望：基于文献的批判性综述。
Neoplasia. 2018 Mar;20(3):227-232. doi: 10.1016/j.neo.2018.01.002. Epub 2018 Feb 12.
2
Evidence-based radiation oncology in head and neck squamous cell carcinoma.头颈部鳞状细胞癌的循证放射肿瘤学
Radiother Oncol. 2007 Oct;85(1):156-70. doi: 10.1016/j.radonc.2007.04.002. Epub 2007 May 4.
3
Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.放疗和顺铂化疗对头颈部癌患者感音神经性听力损失的相对影响
Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):779-88. doi: 10.1016/j.ijrobp.2008.05.040. Epub 2008 Aug 15.
4
Role of concomitant chemoradiation in locally advanced head and neck cancers.同步放化疗在局部晚期头颈癌中的作用。
Asian Pac J Cancer Prev. 2014;15(10):4147-52. doi: 10.7314/apjcp.2014.15.10.4147.
5
The Head and Neck Radiotherapy Questionnaire: a morbidity/quality-of-life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer.头颈部放疗问卷：一种用于局部晚期头颈部癌放疗临床试验的发病率/生活质量评估工具。
J Clin Oncol. 1993 May;11(5):863-72. doi: 10.1200/JCO.1993.11.5.863.
6
Concurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer.同步化疗与再程放疗用于局部区域复发性头颈癌
Semin Oncol. 2008 Jun;35(3):251-61. doi: 10.1053/j.seminoncol.2008.03.010.
7
Combined concomitant boost radiotherapy and chemotherapy in stage III-IV head and neck carcinomas: a comparison of toxicity and treatment results with those observed after radiotherapy alone.III-IV期头颈癌同步加量放疗与化疗联合应用：毒性及治疗结果与单纯放疗的比较
Ann Oncol. 1997 Jul;8(7):681-4. doi: 10.1023/a:1008260720076.
8
Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer.治疗前贫血与晚期头颈癌放疗及同步化疗疗效降低相关。
Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1087-95. doi: 10.1016/j.ijrobp.2004.07.710.
9
Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer.局部晚期头颈癌诱导化疗后放疗计划的临床实践指南
Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):725-33. doi: 10.1016/j.ijrobp.2008.11.059. Epub 2009 Apr 11.
10
Can concomitant-boost accelerated radiotherapy be adopted as routine treatment for head-and-neck cancers? A 10-year single-institution experience.同步推量加速放疗能否作为头颈部癌症的常规治疗方法？一项为期10年的单机构经验。
Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1431-6. doi: 10.1016/j.ijrobp.2003.09.017.
引用本文的文献
1
Evaluating ChatGPT's recommendations for systematic treatment decisions in recurrent or metastatic head and neck squamous cell carcinoma: Perspectives from experts and junior doctors.评估ChatGPT对复发性或转移性头颈部鳞状细胞癌系统治疗决策的建议：专家和初级医生的观点
Int J Cancer. 2025 Nov 1;157(9):1888-1897. doi: 10.1002/ijc.70001. Epub 2025 Jul 19.
2
Combined CA125, NSE, and multiple inflammatory indices for diagnosis of oral squamous cell carcinoma.联合CA125、NSE及多种炎症指标用于口腔鳞状细胞癌的诊断。
Front Oncol. 2025 May 19;15:1543055. doi: 10.3389/fonc.2025.1543055. eCollection 2025.
3
Evaluation of Interfractional Setup Uncertainties and Calculation of Adequate CTV-PTV Margin for Head and Neck Radiotherapy using Electronic Portal Imaging Device.使用电子射野影像装置评估头颈部放疗中分次间摆位不确定性及计算合适的临床靶区-计划靶区边界
J Biomed Phys Eng. 2025 Feb 1;15(1):5-14. doi: 10.31661/jbpe.v0i0.2211-1565. eCollection 2025 Feb.
4
Assessment of multispecies biofilm growth on root canal dentin under different radiation therapy regimens.评估不同放射治疗方案下根管牙本质上多菌种生物膜的生长情况。
Clin Oral Investig. 2024 May 18;28(6):324. doi: 10.1007/s00784-024-05719-x.
5
A real-world evaluation of tislelizumab in patients with head and neck cancer.替雷利珠单抗用于头颈癌患者的真实世界评估。
Transl Cancer Res. 2024 Feb 29;13(2):808-818. doi: 10.21037/tcr-23-1502. Epub 2024 Feb 4.
6
Trehalose versus carboxymethylcellulose oral spray for relieving radiation-induced xerostomia in head and neck cancer patients: a randomized controlled trial.海藻糖与羧甲基纤维素口腔喷雾缓解头颈部癌症患者放疗后口干症的随机对照试验。
BMC Oral Health. 2023 May 13;23(1):288. doi: 10.1186/s12903-023-02966-4.
7
Induction Therapy With Cisplatin, 5-Fluorouracil, Leucovorin, and Paclitaxel in Patients With Head and Neck Cancer.头颈部癌症患者采用顺铂、5-氟尿嘧啶、亚叶酸钙和紫杉醇进行诱导治疗。
In Vivo. 2023 May-Jun;37(3):1339-1345. doi: 10.21873/invivo.13215.
8
Expression of gene on tumor-associated macrophages of head and neck squamous cell carcinoma, and its correlation with clinical outcome.头颈部鳞状细胞癌肿瘤相关巨噬细胞中 基因的表达及其与临床结局的相关性。
Oncoimmunology. 2023 Apr 18;12(1):2203073. doi: 10.1080/2162402X.2023.2203073. eCollection 2023.
9
Longitudinal Molecular Profiling of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma.转移性肾细胞癌患者循环肿瘤细胞的纵向分子谱分析。
J Clin Oncol. 2022 Nov 1;40(31):3633-3641. doi: 10.1200/JCO.22.00219. Epub 2022 May 26.
10
Radioprotective effects and mechanism of HL-003 on radiation-induced salivary gland damage in mice.HL-003 对小鼠放射性唾液腺损伤的防护作用及其机制。
Sci Rep. 2022 May 19;12(1):8419. doi: 10.1038/s41598-022-12581-y.
本文引用的文献
1
Profile of European proton and carbon ion therapy centers assessed by the EORTC facility questionnaire.欧洲癌症研究与治疗组织（EORTC）设施调查问卷对欧洲质子和碳离子治疗中心的评估概况
Radiother Oncol. 2017 Aug;124(2):185-189. doi: 10.1016/j.radonc.2017.07.012. Epub 2017 Jul 29.
2
Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis.头颈部癌放疗分割的作用（MARCH）：一项更新的荟萃分析。
Lancet Oncol. 2017 Sep;18(9):1221-1237. doi: 10.1016/S1470-2045(17)30458-8. Epub 2017 Jul 27.
3
Immunotherapy: Who Is Eligible?免疫疗法：哪些人适合？
Otolaryngol Clin North Am. 2017 Aug;50(4):867-874. doi: 10.1016/j.otc.2017.04.006.
4
Dose-volume correlates of mandibular osteoradionecrosis in Oropharynx cancer patients receiving intensity-modulated radiotherapy: Results from a case-matched comparison.接受调强放疗的口咽癌患者下颌骨放射性骨坏死的剂量-体积相关性：病例匹配比较结果
Radiother Oncol. 2017 Aug;124(2):232-239. doi: 10.1016/j.radonc.2017.06.026. Epub 2017 Jul 18.
5
NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.NCCN 指南解读：头颈部肿瘤，第 2.2017 版。
J Natl Compr Canc Netw. 2017 Jun;15(6):761-770. doi: 10.6004/jnccn.2017.0101.
6
Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer.调强质子治疗与口咽癌放射性骨坏死
Radiother Oncol. 2017 Jun;123(3):401-405. doi: 10.1016/j.radonc.2017.05.006. Epub 2017 May 23.
7
Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual.头颈部肿瘤—美国癌症联合委员会第八版癌症分期手册的重大变化。
CA Cancer J Clin. 2017 Mar;67(2):122-137. doi: 10.3322/caac.21389. Epub 2017 Jan 27.
8
Cancer Statistics, 2017.《2017 年癌症统计》
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
9
E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.E1308：诱导化疗后降低剂量放疗联合西妥昔单抗每周治疗人乳头瘤病毒相关可切除口咽鳞状细胞癌患者的II期试验 - ECOG-ACRIN癌症研究组
J Clin Oncol. 2017 Feb 10;35(5):490-497. doi: 10.1200/JCO.2016.68.3300. Epub 2016 Dec 28.
10
Outcomes and prognostic factors for squamous cell carcinoma of the oral tongue in young adults: a single-institution case-matched analysis.年轻成年人舌鳞状细胞癌的治疗结果及预后因素：一项单机构病例对照分析。
Eur Arch Otorhinolaryngol. 2017 Mar;274(3):1683-1690. doi: 10.1007/s00405-016-4419-1. Epub 2016 Dec 8.
Zotero 插件